We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




NIH’s Observational Medical Outcomes Partnership Seeks Public Feedback on Research Priorities

By LabMedica International staff writers
Posted on 17 Sep 2012
The Foundation for the US National Institutes of Health (Bethesda, MD, USA) managed Observational Medical Outcomes Partnership (OMOP) is seeking public feedback on proposed research priorities and tasks. More...


OMOP was formed in 2008 to conduct methodologic research to inform the suitable use of observational healthcare data for studying the effects of medical products. OMOP has generated empirical evidence about the performance of observational analysis methods to identify real risks of medical products and discriminate from false findings. The basic goal of this research is to develop and evaluate standardized algorithms that can effectively distinguish positive from negative controls, and to understand how an estimated effect from an observational study relates to the true relationship between medical product exposure and adverse events.

As part of its research, OMOP has developed tools and capabilities for transforming, characterizing, and examining disparate data sources across the healthcare delivery spectrum, and has established a shared resource to enable collaborative research. OMOP’s research continues to reiterate the idea that advancing the science of observational research requires an empirical and reproducible approach to methodology and its systematic application.

To continue the effort, the OMOP executive board proposed a series of priorities, infrastructure tasks, and research tasks to guide the development of OMOP’s research agenda for 2013-2016.

The OMOP executive board is seeking comment on the adequacy and completeness of the research priorities and tasks. “Receiving public feedback regarding OMOP’s work is vital to our success,” said OMOP executive board member, Ronald Krall, MD. “We want to make sure we hear every idea about how to use healthcare data to improve the safety and effectiveness of medical products.”

The proposed research priorities and tasks are found on the OMOP website with instructions on how to provide feedback. Comments can be given through September 15, 2012.

Established by the United States Congress to support the mission of the NIH--improving health through scientific discovery in the search for cure--the Foundation for the NIH is a leader in identifying and addressing complex scientific and health issues.

Related Links:
Foundation for the US National Institutes of Health
Observational Medical Outcomes Partnership


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Electrolyte Analyzer
CBS-4000 (CBS-400)
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.